Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial
We use essential cookies for the site to work and, with your permission, Google Analytics cookies to understand how the site is used. You can change your choice at any time. Privacy and Cookie Policy.